PATENT CLAIM ANALYSIS

Application Number: 15869929
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to the treatment or prevention of tinnitus. More precisely, the present invention relates to a compound modulating chloride co-transporter NKCC1 (chloride co-transporter modulator) for use in the treatment of tinnitus. In addition, the present invention concerns pharmaceutical compositions comprising such an NKCC1 chloride co-transporter modulator as an active agent, a method for the treatment or prevention of tinnitus by administering such a chloride co-transporter modulator, an a screening method for the identification and characterization of compounds capable of modulating chloride co-transporter NKCC1.

Claim (Index 13):
The method of  claim 1 , wherein the compound is selected from CCC interacting protein (CIP1) or a functional peptide derived therefrom, N-ethyimaleimide (NEM) or staurosporin.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 2.02128
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14443154', '14087244', '13380921', '14894621', '11251724']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7592748170908258
- 35 USC 102 Novelty (BERT): 0.556279058380571
- Combined Prediction Score: 0.7389752412198003
- Mean Citation Score: 308.9860060000001
- Max Citation Score: 461.20798
- Similarity Product: 321.1097707298899

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test